Sterling Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Global leader in steroidal APIs
One of their notable products is DROSPIRENONE, with a corresponding US DMF Number 21733.
Remarkably, this DMF maintains an Active status since its submission on June 27, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 08, 2013, and payment made on April 24, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II